SAN

77.36

+2.83%↑

ARGX

730.6

+2.79%↑

SHL.DE

34.97

+2.67%↑

PHIA

22.85

+3.77%↑

FRE

37.13

+1.7%↑

SAN

77.36

+2.83%↑

ARGX

730.6

+2.79%↑

SHL.DE

34.97

+2.67%↑

PHIA

22.85

+3.77%↑

FRE

37.13

+1.7%↑

SAN

77.36

+2.83%↑

ARGX

730.6

+2.79%↑

SHL.DE

34.97

+2.67%↑

PHIA

22.85

+3.77%↑

FRE

37.13

+1.7%↑

SAN

77.36

+2.83%↑

ARGX

730.6

+2.79%↑

SHL.DE

34.97

+2.67%↑

PHIA

22.85

+3.77%↑

FRE

37.13

+1.7%↑

SAN

77.36

+2.83%↑

ARGX

730.6

+2.79%↑

SHL.DE

34.97

+2.67%↑

PHIA

22.85

+3.77%↑

FRE

37.13

+1.7%↑

Home・Aktien・Carl Zeiss Meditec AG

Carl Zeiss Meditec AG

Open

BrancheGesundheitswesen

26.78 1.29

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

26.06

Max

26.88

Schlüsselkennzahlen
By Trading Economics
Einkommen	-66M 15M
Verkäufe	524M 991M
KGV Branchendurchschnitt	16.162 49.888
EPS	0.22
Dividendenrendite	2.13
Gewinnspanne	1.48
Angestellte	5,798
EBITDA	-73M 113M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+5.37% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	2.13% 2.38%
Nächstes Ergebnis	6. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	40M 2.3B
Vorheriger Eröffnungskurs	25.49
Vorheriger Schlusskurs	26.78

Nachrichtenstimmung

By Acuity

59%

41%

278 / 344 Ranking in Healthcare

Carl Zeiss Meditec AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Carl Zeiss Meditec AG Prognose

Kursziel

By TipRanks

5.37% Vorteil

12-Monats-Prognose

Durchschnitt 27.65 EUR 5.37%

Hoch 32 EUR

Tief 21.7 EUR

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Carl Zeiss Meditec AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

9 ratings

Buy

Halten

Sell

Basierend auf 9 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Carl Zeiss Meditec AG – Dist abgegeben haben.

Stimmung

By Acuity

278 / 344 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.